Tryp Therapeutics Inc. Share Price Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | 0.00% | +50.00% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 7.29M 5.36M 447M |
---|---|---|---|---|---|
Net income 2024 * | -5M -3.67M -306M | Net income 2025 * | -5M -3.67M -306M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.31% |
1st Jan change | Capi. | |
---|---|---|
+29.41% | 49.18B | |
+0.63% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.78% | 18.71B | |
+8.19% | 13.26B | |
+32.95% | 12.32B | |
-1.37% | 11.99B |
- Stock Market
- Equities
- TYP Stock
- TRYP Stock